|
|
||||||||
Ann Thorac Surg 2001;71:868-871
© 2001 The Society of Thoracic Surgeons
a Division of Cardiothoracic Surgery, University of Washington, Seattle, Washington, USA
b Department of Anesthesia, Childrens Hospital and Medical Center, Seattle, Washington, USA
Accepted for publication June 8, 2000.
Address reprint requests to Dr Verrier, Division of Cardiothoracic Surgery, Department of Surgery, University of Washington, Box 356310, 1959 NE Pacific St, Seattle, WA 98195-6310
e-mail: verrier{at}ctd.surgery.washington.edu
| Abstract |
|---|
|
|
|---|
Methods. We investigated this hypothesis in 10 anesthetized open-chest piglets (7 to 9 kg) undergoing venoarterial extracorporeal membrane oxygenation after placement of minor-axis sonomicrometry crystals and left ventricular micromanometer. The left atrial partial pressure of oxygen was made hypoxemic (25 to 40 mm Hg) after initiation of extracorporeal membrane oxygenation by ventilation with a hypoxic gas mixture. Left ventricular contractile function, including peak LV pressure, shortening fraction, maximum rate of increase of left ventricular pressure, velocity of circumferential fiber shortening, end-systolic pressureminor axis dimension relationship, and preload recruitable dimensional stroke work, was measured or calculated on extracorporeal membrane oxygenation before (baseline) and at 4 and 6 hours after rendering the left atrial blood hypoxemic.
Results. Left ventricular shortening fraction and velocity of circumferential fiber shortening were significantly lower (p < 0.05) at 4 and 6 hours when compared with baseline. The slope of the end-systolic pressureminor axis dimension relationship decreased but was not significantly different at 4 and 6 hours when compared with baseline owing to poor linear correlation (r = 0.30 to 0.93). The preload recruitable dimensional stroke work was more linear (r = 0.87 to 0.99), and the slope was significantly lower (p < 0.01) at 4 and 6 hours when compared with baseline.
Conclusions. Hypoxemic cardiac output from the left ventricle during venoarterial extracorporeal membrane oxygenation is associated with depression of left ventricular systolic function in this animal model. Current use of venoarterial extracorporeal membrane oxygenation for respiratory support may not provide adequate oxygen supply to the myocardium.
| Introduction |
|---|
|
|
|---|
Recent studies using radioactive microspheres [1416] and shunt equation [17] showed that coronary perfusion during ECMO is predominantly by blood from the LV when bypass flow rate is less than total cardiac output [17]. This means that coronary perfusion during VA ECMO in patients with respiratory failure is predominantly with hypoxemic blood returning from the pulmonary circulation. Hence, we postulated that the perfusion of the coronary circulation with desaturated blood from the LV may in part contribute to the decrease in ventricular function that has been reported to occur during VA ECMO.
| Material and methods |
|---|
|
|
|---|
While on ECMO, data were collected before (baseline) and at 4 and 6 hours after rendering LA blood hypoxemic. Qualitative two-dimensional epicardial echocardiography was performed before and during ECMO to rule out any distortion of LV shape.
This study was reviewed and approved by the Animal Care Committee of our institution. All animals received humane care in compliance with the "Principles of Laboratory Animal Care" formulated by the National Society for Medical Research and the "Guide for Care and Use of Laboratory Animals" (National Institutes of Health, publication 86-23, revised 1985).
| Results |
|---|
|
|
|---|
Qualitative two-dimensional epicardial echocardiography performed during data acquisition did not show any evidence of septal flattening or deviation, which can distort the concentricity of the LV and invalidate our function data. The average number of cardiac cycles obtained for analysis during each data acquisition was 13 (range, 6 to 23 cycles). Mean hemodynamics and ejection phase indices in Table 1 showed no significant changes in heart rate and end-diastolic dimension at 4 and 6 hours when compared with baseline. Maximum rate of increase of LV pressure showed a gradual decline at 4 and 6 hours although it did not achieve statistical significance. Peak LV pressure likewise showed a gradual decline that became statistically significant (p < 0.05) at 6 hours after decreasing the LA PO2. Percent LV shortening fraction and velocity of circumferential fiber shortening decreased significantly (p < 0.05) at 4 and 6 hours after reducing LA PO2.
|
|
|
| Comment |
|---|
|
|
|---|
Venoarterial ECMO augments systemic oxygenation in patients with severe respiratory failure, and cardiac performance in these patients should theoretically improve because their heart are structurally normal. However, sustained and even progressive deterioration of cardiac function in these patients after initiation of ECMO can be related to multiple causes including myocardial injury after ischemia and reoxygenation. Recent studies [1417] have suggested that inadequate delivery of oxygenated blood from the ECMO circuit to the coronary circulation may also play a role in the cardiac stun syndrome. Because VA ECMO is a form of partial cardiopulmonary bypass, a small but significant amount of blood still passes through the pulmonary circulation and returns to the LV. This hypoxic blood is ejected from the LV and may provide a significant contribution to coronary perfusion while on ECMO.
The goal of our experiment was to evaluate whether current uses of VA ECMO for primary respiratory failure contributes to a decrease in cardiac performance. Our model simulates the clinical picture of primary pulmonary oxygenation failure, but the structurally normal heart was not subjected to any ischemic injury before ECMO. This eliminates the possible residual effects of myocardial ischemia and reoxygenation injury. We noticed a similar reduction in ejection phase indices, including LV shortening fraction, peak LV pressure, and velocity of circumferential fiber shortening during ECMO as seen clinically [57]. These factors, however, may be less reliable inasmuch as they are influenced by changes in loading condition and heart rate. Furthermore, these changes were also seen in animals placed on VA ECMO alone without rendering LA PO2 hypoxemic during the experiment [18].
We used the ESPDR and PRDSW relationship as load-insensitive indices of cardiac contractility. This allowed us to study the intrinsic inotropic state of the heart in the absence of confounding variables such as preload, afterload, or heart rate. The ESPDR is a modification of the traditional end-systolic pressure-volume relationship in which end-diastolic minor axis diameter is used instead of volume. This linear relationship has been shown to be equally responsive to global changes in LV contractility [19] as reflected by a shift in the slope and x intercept. We demonstrated in our study a decrease in the slope and x intercept of the ESPDR. Neither of these changes, however, was statistically significant because of poor linear correlation. The scattering of data points is probably caused by a shift from a linear to a curvilinear relationship. This change in ESPDR has since been shown in experimental studies to occur in hearts subjected to ischemia or to a decrease in LV end-diastolic volume [20, 21]. This may explain the variability we saw in linear regression coefficients and as such may limit the practical usefulness of this method as a means to evaluate cardiac contractility in this model.
The relationship between cardiac stroke work and end-diastolic minor axis diameter (PRDSW) has been proposed to be a reliable, load-insensitive, and highly linear measure of cardiac contractility even after subjecting the LV to a moderate amount of ischemia and reperfusion injury [22, 23]. Our study showed a significant diminution of intrinsic cardiac contractile function with a significant decrease in the slope of the PRDSW relationship. Although the diameter axis intercept did not show a concomitant increase, the slope of the PRSW relationship has been suggested to be a more reliable and sensitive indicator to changes in contractile function [24]. A decrease in the slope of PRDSW suggested that lowering the LA PO2 did cause a significant decrease in the intrinsic myocardial contractile function that was independent of loading conditions. Furthermore, this decrease in function is unlikely caused by deterioration of the model as similar preparations without LA PO2 hypoxemia did not show a decrease in cardiac function after 6 hours of ECMO [18].
Two animals in our study developed profound ventricular dysfunction resulting in electromechanical dissociation without obvious metabolic or physical causes. This may represent a severe form of hypoxic injury to the myocardium. The ventricle did not respond to direct volume infusion into the LV through the LA catheter. Therefore, electromechanical dissociation in this setting was presumed to be caused by hypoxic injury to the LV as is seen occasionally in patients during clinical VA ECMO.
Even though this study model simulates clinical ECMO for patients with severe respiratory failure, it is limited by its relatively brief duration of support (6 hours) as compared with prolonged duration of ECMO support used clinically. However, measurable impairment of ventricular function was already observed during this brief period of ECMO support, presumably because of hypoxic coronary perfusion. This suggests that a more profound and possibly permanent deterioration of LV function may result from a more prolonged course of ECMO support. A further limitation of this model is that these experimental animals had normal cardiorespiratory function and anatomy before support. This model represents a best-case scenario in that patients with cardiorespiratory failure presupport might be expected to tolerate hypoxia-induced myocardial dysfunction even worse than demonstrated in this model. Certainly myocardial dysfunction secondary to hypoxic coronary perfusion would be poorly tolerated in children with preexisting cardiac disease that require ECMO for circulatory support.
This study has significant implications for clinical management. Children on ECMO often are managed with minimal ventilator support to "rest the lungs" during recovery from respiratory failure. Based on this study, hypoxemia in the pulmonary venous return with native ventricular ejection providing significant coronary perfusion might be a significant cause of progressive myocardial dysfunction. These results suggest that an attempt should be made at maintaining normal pulmonary venous oxygen level when there is significant native ventricular ejection. Attempting to limit ventricular ejection by increasing ECMO flows is an alternative approach that imparts the theoretical risk of significantly increasing afterload to native ventricular ejection. From these results it would appear advisable to provide some ventilator support to maintain LA PO2 greater than 100 mm Hg. These levels would probably be attainable with moderate levels of ventilator support and would remove this as an etiologic factor in myocardial stunning during VA ECMO.
We conclude that oxygen delivery to the myocardium during VA ECMO as used currently for primary respiratory failure may be suboptimal even though indicators of systemic oxygen delivery to other vital organs may be adequate. A substantial portion of coronary perfusion may be provided by desaturated blood from the LV that has circulated through the pulmonary bed and returns to the LV still hypoxemic. This may contribute to the sustained myocardial dysfunction seen clinically in some patients on VA ECMO.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. W. Duncan Mechanical circulatory support for infants and children with cardiac disease Ann. Thorac. Surg., May 1, 2002; 73(5): 1670 - 1677. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |